T2D dampens survival in HCC patients undergoing transarterial chemoembolization
For patients with intermediate-stage hepatocellular carcinoma (HCC) who have undergone transarterial chemoembolization (TACE), long-term survival decreases in the presence of type 2 diabetes (T2D), a study reports.
